
Systamet G 1mg/500mg Tablet SR
Marketer
Systacare Remedies
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Systamet G 1mg/500mg Tablet SR
Diabexe Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined individually by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as abrupt cessation can lead to dangerously elevated glucose, increasing the risk of renal complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive diabetes management plan, which also necessitates a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by sweating, lightheadedness, headache, and tremors. Regular meals and readily available fast-acting glucose sources (e.g., sugary snacks, juice) are essential to mitigate this risk. Alcohol consumption elevates hypoglycemia risk and should be minimized. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections; weight gain may also occur. This medication is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before initiating treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.
Primary Ingredients of Systamet G 1mg/500mg Tablet SR
No information provided. Please provide the text you wish me to rephrase.
Uses of Systamet G 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Systamet G 1mg/500mg Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Systamet G 1mg/500mg sustained-release tablet should be taken with a meal.
Common Side effects of Systamet G 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Systamet G 1mg/500mg Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the entire tablet without chewing, crushing, or fracturing it. The Systamet G 1mg/500mg Extended-Release tablet should be administered with food.
How Systamet G 1mg/500mg Tablet SR works:
Combiforte SR tablets (1mg glimepiride/500mg metformin) unite two distinct antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, retarding intestinal glucose uptake, and enhancing insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Avoid alcohol consumption while taking Systamet G 1mg/500mg SR tablets.
PregnancyCONSULT YOUR DOCTOR
The use of Systamet G 1mg/500mg sustained-release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Extended-release Systamet G 1mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Systamet G 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Systamet G 1mg/500mg SR tablets. Physician consultation is advised. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Systamet G 1mg/500mg sustained-release tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. A low starting dose is typically recommended for individuals with mild to moderate hepatic dysfunction; the medication is contraindicated in those with severe liver disease.
What if you forget to take Systamet G 1mg/500mg Tablet SR :
Should you forget a Systamet G 1mg/500mg Tablet SR dose, administer it promptly. However, near the time for your next scheduled dose, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Systamet G 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
